Pharma Stocks
-
Spotlight On Atea Pharmaceuticals And 2 Other Prominent Penny Stocks
Over the last 7 days, the market has risen 1.1%, with a notable 29% increase over the past year and…
Read More » -
Margin pressure, slower growth outlook may cap upside for Sun Pharma stock
ET Intelligence Group: Sun Pharmaceutical Industries recorded double-digit growth in revenue and net profit for the March quarter; however, operating…
Read More » -
Assessing NervGen Pharma (NasdaqCM:NGEN) Valuation After Its $60 Million Follow On Equity Offering
NervGen Pharma (NGEN) has drawn fresh attention after completing a follow on public equity offering of approximately $60 million, including…
Read More » -
Looking to Buy Bristol Myers Squibb Stock on the Dip? Read This First.
Bristol Myers Squibb‘s (BMY 0.15%) shares are rebounding after sinking roughly 11%. However, the big pharma stock remains below the…
Read More » -
Stocks to Watch for May 25: Hindalco, Eicher Motors, Divi’s Labs, Torrent Pharma, Lupin and more
1 / 12 Hindalco Industries Ltd | The Aditya Birla Group metals flagship reported a sharp rise in standalone fourth-quarter…
Read More » -
AFT Pharmaceuticals Limited Just Missed Earnings – But Analysts Have Updated Their Models
It’s been a pretty great week for AFT Pharmaceuticals Limited (NZSE:AFT) shareholders, with its shares surging 11% to NZ$3.88 in…
Read More » -
Banking giant massively resets Jazz Pharma stock price target
Changes in Wall Street price targets usually arrive in small increments. A few dollars up, a few dollars down, and…
Read More » -
Will Real-World SUBLOCADE Adherence Data Reshape Indivior Pharmaceuticals’ (INDV) Long-Acting OUD Treatment Narrative
In May 2026, Indivior Pharmaceuticals reported two real-world evidence studies showing that adherence to its monthly injectable buprenorphine, SUBLOCADE, was…
Read More » -
Why The Cipher Pharmaceuticals (TSX:CPH) Story Is Shifting As Analysts Lift Valuation Targets
Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge. Cipher Pharmaceuticals is…
Read More » -
Here’s Why We Think AFT Pharmaceuticals (NZSE:AFT) Is Well Worth Watching
Investors are often guided by the idea of discovering ‘the next big thing’, even if that means buying ‘story stocks’…
Read More »